$0.00
(0.00%)
| Today's Open | $226.17 |
|---|---|
| Previous Close | $225.18 |
| Daily Range | $226.00 - $234.20 |
| 52-Week Range | $126.39 - $234.46 |
| Market Cap | $54.9B |
| P/E Ratio | 35.74 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,334,096 |
| Average Daily Volume | 1,351,196 |
| Current FY EPS | $7.88 |
Sector
Healthcare
Industry
Drugs
Biogen Idec (BIIB) Description
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/
News & Commentary
Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.2 Scariest Dividend Stocks in Health Care
The yields look great, but these 2 health-care dividend stocks could be the scariest ones around in the near future.BIIB's Top Competitors
(2.73%)
(2.02%)
(1.31%)
